These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25969567)

  • 41. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type.
    Mottl AK; Divers J; Dabelea D; Maahs DM; Dolan L; Pettitt D; Marcovina S; Imperatore G; Pihoker C; Mauer M; Mayer-Davis EJ;
    Pediatr Nephrol; 2016 Jun; 31(6):933-40. PubMed ID: 26754041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
    Mottl AK; Buse JB; Ismail-Beigi F; Sigal RJ; Pedley CF; Papademetriou V; Simmons DL; Katz L; Mychaleckyj JC; Craven TE
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1693-1702. PubMed ID: 30361335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina.
    Çimen T; Efe TH; Akyel A; Sunman H; Algül E; Şahan HF; Erden G; Özdemir Ş; Alay EF; Doğan M; Yeter E
    Angiology; 2016 Oct; 67(9):846-53. PubMed ID: 26744512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long Term Effects of Liraglutide in Japanese Patients with type 2 Diabetes Among the Subgroups with Different Renal Functions: Results of 2-Year Prospective Study.
    Hiramatsu T; Ozeki A; Ishikawa H; Furuta S
    Drug Res (Stuttg); 2017 Nov; 67(11):640-646. PubMed ID: 28738426
    [No Abstract]   [Full Text] [Related]  

  • 47. Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function.
    Petrykiv S; Sjöström CD; Greasley PJ; Xu J; Persson F; Heerspink HJL
    Clin J Am Soc Nephrol; 2017 May; 12(5):751-759. PubMed ID: 28302903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
    Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
    Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effectiveness of patient activation intervention on type 2 diabetes mellitus glycemic control and self-management behaviors: A systematic review of RCTs.
    Almutairi N; Hosseinzadeh H; Gopaldasani V
    Prim Care Diabetes; 2020 Feb; 14(1):12-20. PubMed ID: 31543458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
    Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
    Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.
    Chang LH; Hwu CM; Chu CH; Lin YC; Huang CC; You JY; Chen HS; Lin LY
    J Endocrinol Invest; 2021 Dec; 44(12):2609-2619. PubMed ID: 33834419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
    Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
    J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes.
    Sbroma Tomaro E; Pippi R; Reginato E; Aiello C; Buratta L; Mazzeschi C; Perrone C; Ranucci C; Tirimagni A; Russo A; Fatone C; Fanelli C; De Feo P
    Nutr Metab Cardiovasc Dis; 2017 Aug; 27(8):688-694. PubMed ID: 28735815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).
    Yoon SA; Han BG; Kim SG; Han SY; Jo YI; Jeong KH; Oh KH; Park HC; Park SH; Kang SW; Na KR; Kang SW; Kim NH; Jang YH; Shin SH; Cha DR
    Diabetes Obes Metab; 2017 Apr; 19(4):590-598. PubMed ID: 28019072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers.
    Heerspink HJL; Sjöström CD; Inzucchi SE; Hallow MK; Cain VA; Rossing P; Stefansson BV; Sartipy P
    Diabetes Obes Metab; 2019 Mar; 21(3):720-725. PubMed ID: 30414240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum endothelial cell specific molecule-1 (endocan) levels in patients with obstructive sleep apnea.
    Bingol Z; Kose M; Pıhtılı A; Akpınar T; Tukek T; Kıyan E
    Biomark Med; 2016; 10(2):177-84. PubMed ID: 26808694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated endocan concentration is associated with coronary slow flow.
    Ye MF; Zhao ZW; Luo YK; Dong XF; Yan YM
    Scand J Clin Lab Invest; 2016 Sep; 76(5):345-8. PubMed ID: 27180882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.